Thioredoxin inhibits tumor necrosis factor- or interleukin-1-induced NF- κB activation at a level upstream of NF-κB-inducing kinase

Antioxidants and Redox Signaling

Volumn 2, Issue 1, 2000, Pages 83-92

  Takeuchi, Junko ^a   Hirota, Kiichi ^a,c   Itoh, Tatsuya ^a   Shinkura, Reiko ^b   Kitada, Kazuhiro ^b   Yodoi, Junji ^b   Namba, Tsunehisa ^a   Fukuda, Kazuhiko ^a  

^a KYOTO UNIVERSITY HOSPITAL   (Japan)

^b KYOTO UNIVERSITY   (Japan)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; PROTEIN KINASE; STRESS ACTIVATED PROTEIN KINASE; THIOREDOXIN; TUMOR NECROSIS FACTOR;

ARTICLE; CONTROLLED STUDY; GENE INDUCTION; GENE OVEREXPRESSION; HELA CELL; HUMAN; HUMAN CELL; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

EID: 0034110596     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/ars.2000.2.1-83     Document Type: Article

References (46)

1. AKIBA, H., NAKANO, H., NISHINAKA, S., SHINDO, M., KOBATA, T., ATSUTA, M., MORIMOTO, C., WARE, C.F., MALININ, N.L., WALLACH, D., YAGIATA, H., and OKUMURA, K. (1998). CD27, a member of the tumor necrosis factor receptor superfamily, activates NF-κB and stress-activated protein kinase/c-Jun N-terminal kinase via TRAF2, TRAF5, and NF-κB-inducing kinase. J. Biol. Chem. 273, 13353-13358.
2. BAEUERLE, P.A. (1998). IκB-NF-κB structures: at the interface of inflammation control. Cell 95, 729-731.
3. BAEUERLE, P.A., and BALTIMORE, D. (1996). NF-κB: ten years after. Cell 87, 13-20.
4. BAEUERLE, P.A., and HENKEL, T. (1994). Function and activation of NF-kappa B in the immune system. Annu. Rev. Immunol. 12, 141-179.
5. BALDWIN, A.S. (1996). The NF-κB and IκB proteins: new discoveries and insights. Annu. Rev. Immunol. 14, 649-681.
6. COHEN, L., HENZEL, W.J., and BAEUERLE, P.A. (1998). IKAP is a scaffold protein of the IκB kinase complex. Nature 395, 292-296.
7. DALTON, T.P., SCHERTZER, H.G., and PUGA, A. (1999). Regulation of gene expression by reactive oxygen. Annu. Rev. Pharmacol. Toxicol. 39, 67-101.
8. DIDIONATE, J.A., HAYAKAWA, M., ROTHWARF, D.M., ZANDI, E., and KARIN, M. (1997). A cytokine-responsive IκB kinase that activates the transcription factor NF-κB. Nature 388, 548-554.
9. DIEKMANN, D., ABO, A., JOHNSON, C., SEGAL, A.W., and HALL, A. (1994). Interaction of Rac with p67phox and regulation of phagocytic NADPH oxidase activity. Science 265, 531-533.
10. GALLEGOS, A, GASDASKA, J.R., TAYLOR, C.W., PAINE-MURRIETA, G.D., GOODMAN D., GASDASKA P.Y., BERGGREN, M., BRIEHL, M.M., and POWIS, G. (1996). Transfection with human thioredoxin increases cell proliferation and a dominant-negative mutant thioredoxin reverses the transformed phenotype of human breast cancer cells. Cancer Res. 56, 5765-5770.
11. HASHIMOTO, S., MATSUMOTO, K., GON, Y., FURUICHI, S., MARUOKA, S., TAKESHITA, I., HIROTA, K., YODOI, J., and HORIE, T. (1999). Thioredoxin negatively regulates p38 MAP kinase activation and IL-6 production by tumor necrosis factor-alpha. Biochem. Biophys. Res. Commun. 258, 443-447.
12. HIROTA, K., MATSUI, M., IWATA, S., NISHIYAMA, A., MORI, K., and YODOI, J. (1997). AP-1 transcriptional activity is regulated by a direct association between thioredoxin and Ref-1. Proc. Natl. Acad. Sci. USA 94, 3633-3638.
13. HIROTA, K., MURATA, M., SACHI, Y., NAKAMURA, H., TAKEUCHI, J., MORI, K., YODOI, J. Distinct roles of thioredoxin in the cytoplasm and in the nucleus: a two step mechanism of redox regulation of transcription factor NF-κB. J. Biol. Chem. 274, 27891-27897.
14. ICHIJO, H., NISHIDA, E., IRIE, K., TEN DIJKE, P., SAITOH, M., MORIGUCHI, T., TAKAGI, M., MATSUMOTO, K., MIYAZONO, K., and GOTOH, Y. (1997). Induction of apoptosis by ASK1, a mammalian MAP-KKK that activates SAPK/JNK and p38 signaling pathways. Science 275, 90-94.
15. IRANI, K., XIA, Y., ZWEIER, J.L., SOLLOT, S.J., DER, C.J., FEARON, E.R., SUNDARESAN, M., FINKEL, T., and GOLDSCHMIDT-CLERMONT, P.J. (1997). Mitogenic signaling mediated by oxidants in Ras-transformed fibroblast. Science 275, 1649-1652.
16. KANG, S.W., BAINES, I.C., and RHEE, S.G. (1998a). Characterization of a mammalian peroxiredoxin that contains one conserved cysteine. J. Biol. Chem. 273, 6303-6311.
17. KANG, S.W., CHAE, H.Z., SEO, M.S., KIM, K., BAINES, I.C., and RHEE, S.G. (1998b). Mammalian peroxiredoxin isoforms can reduce hydrogen peroxide generated in response to growth factors and tumor necrosis factor-α. J. Biol. Chem. 273, 6297-6302.
18. KURODA, S., FUKATA, M., KOBAYASHI, K., NAKAFUKU, K., NOMURA, N., IWAMATSU, A., and KAIBUCHI, K. (1996). Identification of IQGAP as a putative target for small GTPases, Cdc42 and Rac1. J. Biol. Chem. 271, 23363-23367.
19. LEE, F.S., PETERS, R.T., DANG, L.C., and MANIATIS, T. (1998). MEKK1 activates both IκB kinase α and IκB kinase β. Proc. Natl. Acad. Sci. USA 95, 9319-9324.
20. LIU, Z.-G., HSU, H., GOEDDEL, D.V., and KARIN, M. (1996). Dissection of TNF receptor 1 effector function: JNK activation is not linked to apoptosis while NF-κB activation prevents cell death. Cell 87, 565-576.
21. LOS, M., SCHENK, H., HEXEL, K., BAEUERLE, P.A., DRÖGE, W., and SCHULZE-OSTHOFF, K. (1995). IL-2 gene expression and NF-κB activation through CD28 requires reactive oxygen production by 5-lipooxigenase. EMBO J. 14, 3731-3740.
22. MALININ, N.L., BOLDIN, M.P., KOVALENKO, A.V., and WALLACH, D. (1997). MAP3K-related kinase involved in NF-κB induction by TNF, CD95 and IL-1. Nature 385, 540-544.
23. MERCURIO, F., ZHU, H., MURRAY, B.W., SHEVCHENKO, A., BENNETT, B.L., LI, J.W., YOUNG, D.B., BARBOSA, M., MANN, M., MANNING, A., and RAO, A. (1997). IKK-1 and IKK-2: cytokine-activated IκB kinases essential for NF-κB activation. Science 278, 860-866.
24. 2 and antioxidants have opposite effects on activation of NF-kappa B and AP-1 in intact cells: AP-1 as secondary antioxidant-responsive factor. EMBO J. 12, 2005-2015.
25. MITSUI, A., HIRAKAWA, T., and YODOI, J. (1992). Reactive oxygen-reducing and protein-refolding activities of adult T cell leukemia-derived factor/human thioredoxin. Biochem. Biophys. Res. Commun. 186, 1220-1226.
26. NAKAMURA, H., NAKAMURA, K., and YODOI, J. (1997). Redox regulation of cellular activation. Annu. Rev. Immunol. 15, 351-369.
27. NISHITOH, H., SAITOH, M., MOCHIDA, Y., TAKEDA, K., NAKANO, H., ROTHE, M., MIYAZONO, K., and ICHIJO, H. (1998). ASK1 is essential for JNK/SAPK activation by TRAF2. Mol. Cell. 2, 389-395.
28. NISHIYAMA, A., OHNO, T., IWATA, S., MATSUI, M., HIROTA, K., MASUTANI, H., NAKAMURA, H., and YODOI, J. (1999). Demonstration of the interaction of thioredoxin with p40phox, a phagocyte oxidase component using yeast two-hybrid system. Immunol. Lett. 68, 155-159.
29. PAHL, H.L., and BAEUERLE, P.A. (1994). Oxygen and the control of gene expression. BioEssays 16, 497-502.
30. PRIGMORE, E., AHMED, S., BEST, A., KOZMA, R., MANSER, E., SEGAL, A.W., and LIM, L. (1995). A 68-kDa kinase and NADPH oxidase component p67phox are targets for Cdc42HS and Rac1 in neutrophils. J. Biol. Chem. 270, 10717-10722.
31. ROTHE, M., WONG, S.C., HENZEL, W.J., and GOEDDEL, D.V. (1994). A novel family of putative signal transducers associated with the cytoplasmic domain of the 75 KDa tumor necrosis factor receptor. Cell 78, 681-692.
32. ROTHE, M., PAN, M.G., HENZEL, W.J., AYRES, T.M., and GOEDDEL, D.V. (1995). The TNFR2-TRAF signaling complex contains two novel proteins related to Baculoviral inhibitor of apoptosis proteins. Cell 83, 1243-1252.
33. SACHI, Y., HIROTA, K., MASUTANI, H., TODA, K.-I., OKAMOTO, T., TAKIGAWA, M., and YODOI, J. (1995). Induction of ADF/TRX by oxidative stress in keratinocytes and lymphoid cells. Immunol. Lett. 44, 189-193.
34. SAITO, M., NISHITOH, H., FUJII, M., TAKEDA, K., TOBIUME, K., MIYAZONO, K., and ICHIJO, H. (1998). Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (Ask) 1. EMBO J. 17, 2596-2606.
35. SCHENK, H., KLEIN, M., ERDBRÜGGER, W., DRÖGE, W., and SCHULZE-OSTHOFF, K. (1994). Distinct effects of thioredoxin and antioxidants on the activation of transcription factors NF-κB and AP-1. Proc. Natl. Acad. Sci. USA 91, 1672-1676.
36. SEN, C., and PACKER, L. (1996). Antioxidant and redox regulation of gene expression. FASEB J. 72, 709-720.
37. SHINKURA, R., KITADA, K., MATSUDA, F., TASHIRO, K., IKUTA, K., SUZUKI, M., KOGISHI, K., SERIKAWA, T., and HONJO, T. (1999). Alymphoplasia is caused by a point mutation in the mouse gene encoding NF-κB-inducing kinase. Nature Genet. 22, 74-77.
38. SULCINER, D.J., IRAN, K., YU, Z.-X., FERRANS, V.J., GOLDSCHMIDT-CLERMONT, P., and FINKEL, T. (1996). rac1 regulates a cytokine-stimulated, redox-dependent pathway necessary for NF-κB activation. Mol. Cell. Biol. 16, 7155-7121.
39. 2 for platelet-derived growth factor signal transduction. Science 270, 296-299.
40. SUNDARESAN, M., YU, Z.-X., FERRANS, V.J., SULCINER, D.J., GUTKIND, J.S., IRANI, K., GOLDSCHMIDT-CLERMONT, P.J., and FINKEL, T. (1996). Regulation of reactive-oxygen-species generation in fibroblasts by Rac1. Biochem. J. 318, 379-382.
41. SUZUKI, Y.J., FORMAN, H.J., and SEVANIAN, A. (1997). Oxidants as stimulators of signal transduction. Free Rad. Biol. Med. 22, 269-285.
42. TAGAYA, Y., MAEDA, Y., MITSUI, A., KONDO, N., MASUTANI, H., MAMURO, J., BROWN, N., ARAI, K-I., YOKOTA, T., WAKASUGI, H., and YODOI, J. (1989). ATL-derived factor (ADF), an IL-2 receptor/Tac inducer homologous to thioredoxin; possible involvement of dithiol-reduction in the IL-2 receptor system. EMBO J. 8, 757-764.
43. TAKEUCHI, M., ROTHE, M., and GOEDDEL, D.V. (1996). Anatomy of TRAF2. Distinct domains for nuclear factor-kappa B activation and association with tumor necrosis factor signaling proteins. J. Biol. Chem. 271, 19935-19942.
44. TANIGUCHI, Y., TANIGUCHI-UEDA, Y., MORI, K., and YODOI, J. (1996). A novel promoter sequence is involved in the oxidative stress-induced expression of the adult T-cell leukemia-derived factor (ADF)/human thioredoxin (Trx) gene. Nucleic Acids Res. 24, 2746-2752.
45. YAMAOKA, S., COURTOIS, G., BESSIA, C., WHITESIDE, S.T., WEIL, R., AGOU, F., KIRK, H.E., KAY, R.J., and ISRAËL, A. (1998). Complementation cloning of NEMO, a component of IκB kinase complex essential for NF-κB activation. Cell 93, 1231-1240.
46. ZANDI, E., ROTHWART, D.M., DELHASE, M., HAYAKAWA, M., and KARIN, M. (1997). The IκB Kinase complex (IKK) contains two kinase subunits, IKKα and IKKβ, necessary for IκB phosphorylation and NF-κB activation. Cell 91, 243-252.